Cadrenal Therapeutics (CVKD) Times Interest Earned (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Times Interest Earned of -$7.52 for Q3 2024, up 97.28% sequentially from -$276.28 in Q2 2024, and down 387.3% YoY from $2.62 in Q4 2023.
Cadrenal Therapeutics (CVKD) Times Interest Earned (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Times Interest Earned for 3 years, with the latest figure at -$7.52 in Q3 2024.
- Quarterly Times Interest Earned fell 387.3% year-over-year to -$7.52 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$24.3 (down 141.57% YoY) and the FY2023 annual result came in at -$3.5, up 37.95% from the prior year.
- Times Interest Earned rose to -$7.52 in Q3 2024 per CVKD's latest filing, from -$276.28 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$1.03 in Q2 2023 and troughed at -$3850.0 in Q1 2024.
- A 3-year average of -$442.96 and a median of -$65.63 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned jumped 98.63% in 2023, then plunged 74008.92% in 2024.
- Over 3 years, Times Interest Earned stood at -$59.43 in 2022, then soared by 97.4% to -$1.54 in 2023, then tumbled by 387.3% to -$7.52 in 2024.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$7.52, -$276.28, and -$3850.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -356.31 |
| Jun 30, 2025 | -19.57 |
| Sep 30, 2024 | -7.52 |
| Jun 30, 2024 | -276.28 |
| Mar 31, 2024 | -3,850.03 |
| Sep 30, 2023 | -1.54 |
| Jun 30, 2023 | -1.03 |
| Mar 31, 2023 | -5.20 |
| Dec 31, 2022 | -59.43 |
| Sep 30, 2022 | -71.82 |
| Jun 30, 2022 | -74.83 |
| Mar 31, 2022 | -81.94 |